Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Total KLA Stockholders’ Equity
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Beginning balance (in shares) at Jun. 30, 2022     141,804        
Beginning balance at Jun. 30, 2022 $ 1,399,090 $ 1,401,351   $ 1,061,940 $ 366,882 $ (27,471) $ (2,261)
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 3,387,277 3,387,277     3,387,277    
Net income attributable to non-controlling interest 74           74
Other comprehensive income (loss) (8,870) (8,870)       (8,870)  
Net issuance under employee stock plans (in shares)     790        
Net issuance under employee stock plans $ 29,930 29,930   29,930      
Repurchase of common stock (in shares) (5,844)   (5,844)        
Repurchase of common stock $ (1,329,714) (1,329,714)   842,467 (2,172,181)    
Cash dividends and dividend equivalents declared (733,547) (733,547)     (733,547)    
Stock-based compensation expense 171,424 171,424   171,424      
Purchase of non-controlling interest (4,294) 1,902   1,902     (6,196)
Disposal of non-controlling interest 8,383           8,383
Ending balance (in shares) at Jun. 30, 2023     136,750        
Ending balance at Jun. 30, 2023 2,919,753 2,919,753   2,107,663 848,431 (36,341) 0
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 2,761,896 2,761,896     2,761,896    
Net income attributable to non-controlling interest 0            
Other comprehensive income (loss) (12,734) (12,734)       (12,734)  
Net issuance under employee stock plans (in shares)     707        
Net issuance under employee stock plans $ 1,908 1,908   1,908      
Repurchase of common stock (in shares) (3,032)   (3,032)        
Repurchase of common stock $ (1,742,501) (1,742,501)   (42,133) (1,700,368)    
Cash dividends and dividend equivalents declared (772,689) (772,689)     (772,689)    
Stock-based compensation expense $ 212,695 212,695   212,695      
Ending balance (in shares) at Jun. 30, 2024 134,425   134,425        
Ending balance at Jun. 30, 2024 $ 3,368,328 3,368,328   2,280,133 1,137,270 (49,075) 0
Increase (Decrease) in Stockholders' Equity              
Net income attributable to KLA 4,061,643 4,061,643     4,061,643    
Net income attributable to non-controlling interest 0            
Other comprehensive income (loss) 50,276 50,276       50,276  
Net issuance under employee stock plans (in shares)     605        
Net issuance under employee stock plans $ 18,853 18,853   18,853      
Repurchase of common stock (in shares) (3,007)   (3,007)        
Repurchase of common stock $ (2,165,635) (2,165,635)   (52,075) (2,113,560)    
Cash dividends and dividend equivalents declared (906,023) (906,023)     (906,023)    
Stock-based compensation expense $ 265,011 265,011   265,011      
Ending balance (in shares) at Jun. 30, 2025 132,023   132,023        
Ending balance at Jun. 30, 2025 $ 4,692,453 $ 4,692,453   $ 2,511,922 $ 2,179,330 $ 1,201 $ 0